Check out Jeeva's latest corporate video to see the future of clinical research! Harsha K Rajasimha, Ph.D., Our founder & CEO, discusses how Jeeva Clinical Trials Inc. Human-Centric Software and CRO Solutions are transforming clinical trials. Engage patients in 100+ languages, promote diversity, and manage studies end-to-end with one unified login from any device. Join us in making clinical trials reflect the global community! https://jeevatrials.com/ #diversity #clinicaltrials #clinicalresearch #jeevatrials #corporatevideo #clinicaltrials
Jeeva Clinical Trials Inc.
生物技术研究
MANASSAS,VA 2,933 位关注者
Modernizing Clinical Research With Human-Centric Software and Turnkey CRO Solutions for Sponsors, CROs, and Researchers
关于我们
Founded by Dr. Harsha Rajasimha after his deeply personal, family, and professional experiences, Jeeva's mission to "Modernize Clinical Research with Human-Centric Software and turnkey CRO solutions" propels their innovative clinical trial management platform with AI and workflow automation under one bundled subscription. Jeeva empowers global biopharmaceutical, medical device, and nutraceutical sponsors, simplifying patient engagement and evidence generation, achieving 70% greater efficiency in research. Trusted by prestigious organizations like Frantz Viral Therapeutics and George Mason University, their technology supports diverse study designs, from traditional to fully decentralized models, across disease areas including oncology and rare diseases. With empathy and determination, team Jeeva has developed a patient-centric and unified platform that enables sponsors to conduct clinical trials more effectively, breaking down barriers and fostering a globally inclusive and diverse participant pool. This includes facilitating remote participation. Powered by AI and automation, Jeeva is transforming the healthcare and life sciences industry, one clinical study at a time. Discover more about how Jeeva is reimagining the future of clinical trials at?https://jeevatrials.com/. The AI-driven Jeeva platform automates and centralizes the schedule of visits and protocol configuration that maps to modules in the platform. Modules include eConsent, ePRO/eCOA/EDC, TeleVisits/VideoVisits, Adverse event capture with MedDRA coding, and patient engagement portal with SMS/email/audio/video communications/reminders/notifications.
- 网站
-
https://www.jeevatrials.com
Jeeva Clinical Trials Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- MANASSAS,VA
- 类型
- 私人持股
- 创立
- 2019
- 领域
- precision medicine、clinical trials、clinical research、natural history study、cell and gene therapy、gene therapy、cell therapy、long term follow up、real world evidence、RWE、Software as a service、Cloud based、decentralized clinical trials、rare disease、rare diseases、patient recruitment、study startup、BYOD、Accelerate clinical trials、Patient registry、Remote touchless econsent、remote touchless clinical research、JEEVA、natural history、observational、interventional、investigational、software、bring your own device、digital health、N-of-1和allofusresearch
地点
-
主要
10432 Balls Ford Rd Suite 300
US,VA,MANASSAS,20109
Jeeva Clinical Trials Inc.员工
动态
-
N=1 Collaborative is breaking barriers and fostering cutting-edge research with N=1 clinical trials. Join the force! Harsha K Rajasimha #clinicaltrials #decentralizedtrials #Nof1Trials
During this week of thanks, we’re proud to recognize?Microsynth AG?for joining The N=1 Collaborative Donated Resource Center by contributing?antisense oligonucleotides (ASOs) tailored for screening purposes. These ASOs are a crucial resource, helping to accelerate early stage therapeutic development. Microsynth AG joins a growing community of companies—including Argonaut Manufacturing Services Inc., Hongene Biotech Corporation, 3billion, Charles River Laboratories, Jeeva Clinical Trials Inc., and ChemGenes—united in the mission to advance individualized treatments. This collaborative model connects academia, industry, and patients, paving the way for broader access to life-changing therapies. Interested in contributing? Contact Nicole Nolen to learn how your company can join us. Every donated resource brings us closer to a future where individualized therapies are more accessible to real-world patients. Developing an individualized therapy? Explore the Donated Resource Center and apply today! https://lnkd.in/ew-Y3K_Z
-
-
Be sure to check out our latest November-December 2024 issue of BioProcess International on product development - available in print and digital! This issue features fascinating articles from talented professionals. Read on for a preview of the articles linked below: From the Editor: November-December 2024 by Cheryl Scott. Temporal Analysis of Biomanufacturing Skill Development: Understanding the Needs of an Industry-4.0 Workforce by Jason Beckwith, Stephen Goldrick, William Nixon, Stavros Kourtzidis. Easing the Pathway for Combination Products: An Australian Regulatory Perspective by Piety Rocha, Heyam Kalla. Driving Sustainability in Biologics Process Development: Innovative Strategies and Technologies by David Roush, Sri Madabhushi. Process Development, Manufacturing, and Clinical Support for Bispecific Antibodies: Chemistry, Manufacturing, and Controls Considerations by Yanhuai (Richard) Ding, Bruce Andrien, Mohosin Sarkar, Mark Aimone, MBA. Biopharmaceutical Cleaning Validation: Experimental Evaluation of the Acceptable Exposure Limit for Inactive Therapeutic-Protein Fragments by Vibha Jawa PhD FAAPS, Joseph R. Cohen, Marisa Joubert, Jonathan Herskovitz, Michelle Monk, Angela Vera, Rizwan Sharnez. Optimized HCP Assay with Reduced Matrix Interference from Protein A: Improved Performance in Dilution Linearity and Spike Recovery by Bulat R Ramazanov, Shenjiang Yu, Khushboo Kapadia, Daria V. Sizova, Helen SooHoo, Emily Sciortino, Becky Phillips, Samantha Cote, Tony Dang, Bing Hu. Regulatory Consequences of New Protein-Impurity Guidelines by Ejvind M?rtz, Thomas Kofoed. Enabling Real-Time, Label-Free Analysis of Single Cells: A Discussion on Analytical Needs in Cell-Therapy Manufacturing by Brian Gazaille, Renee A. Hart. Address Challenges of Bispecifics and Antibody Fragments with Novel Affinity Resins by Chiu Lau-Barre. Reliable Data, Reliable Products: Maintaining Data Integrity in Bioprocessing Workflows (Webcast Recap) by Shweta Nair. From Concept to Cleanroom: Case Studies in Single-Use Fluid Management Collaboration (Webcast Recap) by Greg Verni, Derek Masser, Scott Bendon. Bringing Inclusivity in Cancer Research: How Technology Is Modernizing Clinical Trials by Harsha K Rajasimha. #productdevelopment #clinicaltrials #singleuse #celltherapies #sustainability Follow the link below to read the full issue: https://lnkd.in/gxeTkznH
-
Everest Group’s Life Sciences Clinical Trial Management System (#CTMS) Products PEAK Matrix? Assessment 2024 is out now! Discover how 13 #CTMS providers’ rank in this comprehensive assessment and see who stands out. Medidata Solutions Oracle Veeva Systems @Anju Software BSI Cloudbyz Ennov Octalsoft (Glorant LLC) SimpleTrials CTMS & eTMF SyMetric Clinevo Technologies Clinion Jeeva Clinical Trials Inc. Dive into the insights now! Read on: https://okt.to/WzoH4K Get in touch: Manu Aggarwal Abhishek Singh Chunky Satija Nisarg Shah Apoorva Gupta
-
-
?? The future of clinical trials is here—and it’s decentralized! With Jeeva Clinical Trials Inc. cutting-edge eClinical solutions like EDC, eCOA, and eConsent, we're breaking down barriers in medical research. Patients can now participate from home, bringing global accessibility, enhanced data quality, and real-time engagement to the forefront. Read more from this blog: https://hubs.la/Q02Zk6vp0 #DecentralizedTrials #eClinicalSolutions #PatientEngagement #JeevaClinicalTrials #AskJeeva
-
-
Short video interview series #ExploreWithJeeva episode 12 of 14 is Live! Pharmaceutical Outsourcing asked Harsha K Rajasimha, Ph.D., our Founder & CEO: “What are some challenges that are facing the industry?” He states that numerous challenges persist in the clinical trial industry, like inaccessibility to the underserved population, valley of death, lack of technical feasibility, and many more. Listen to his thoughts and how Jeeva Clinical Trials Inc. can tackle these challenges efficiently through its unified eClinical solutions. Watch the video here: https://lnkd.in/gYV5ThQ8 #clinicaltrials #jeevaclinicaltrials #AskJeeva #clinicalresearch #rarediseases #vallyeofdeath
-
Harsha K Rajasimha, our Founder and CEO is a featured speaker in this outstanding documentary on patient-centric innovation in clinical trial management solutions! #PharmaceuticalOutsourcing #documentary #decentralizedtrials #modernclinicaltrials #clinicaltrials #patientcentric
We are thrilled to announce the release of our NEW documentary, titled "Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs"! The goal of this documentary is to showcase how patient-centric innovations and advanced technologies are transforming clinical trials, accelerating drug development, and improving patient outcomes worldwide. Watch the full documentary now: https://lnkd.in/gy9QXs_X A special thanks to our speakers from the FDA, Catalent Pharma Solutions, Jeeva Clinical Trials Inc., WCG, and Pharmatech Associates, a USP company. #PharmaInnovation #ClinicalTrials #PatientCentricity #DrugDevelopment #DecentralizedTrials #HealthcareTechnology #AIinPharma #BigData #WearableTech #PatientDiversity #ClinicalResearch #PharmaTech #DataDrivenHealthcare #AcceleratingMedicine #FutureOfPharma
-
-
?? We're glad to announce that Jeeva Clinical Trials is joining us as a Bronze Sponsor for the Indo US Bridging RARE Summit 2024! Their support is crucial in accelerating rare disease research through cross-border collaboration, data sharing, and clinical trials. Stay tuned for more updates: https://buff.ly/4aGUWs9 Centre for Cellular and Molecular Biology BRIC-Centre for DNA Fingerprinting and Diagnostics (CDFD) AIIMS (All India Institute of Medical Sciences, New Delhi) Virginia Bio George Mason University BioHealth Innovation, Inc. BioHealth Capital Region Sir Ganga Ram Hospital Aarogya Seva: Global Health Volunteer Alliance #SocietyforIndianAcademyofMedicalGenetics Harsha K Rajasimha Narayanan Govindarajan Reena Kartha Nisha Venugopal Ramya T karur Saundarya M S Indo US Organization for Rare Diseases (IndoUSrare) #JeevaClinicalTrials #bridge4rare #bridgingrare #indousrare #roar4rare #indousrare
-
-
Short video interview series #ExploreWithJeeva episode 11 of 14 is Live! Pharmaceutical Outsourcing asked Harsha K Rajasimha, Ph.D., our Founder & CEO: “Tell us about yourself and Jeeva Clinical Trials.” Watch our passionate leader share his vision and mission to revolutionize clinical trials with innovative patient-centric software solutions to accelerate therapy development and ensure they are available to those who are most in need. Listen to his journey from being a rare dad to a social entrepreneur and the mission that gave birth to Jeeva Clinical Trials Inc. Watch the other episodes here! ??? https://lnkd.in/gR2HnjBE #clinicaltrials #jeevaclinicaltrials #AskJeeva #clinicalresearch #orphandrugs #rareparents
-
?? Exciting News! ?? The Indo US Bridging RARE Summit 2024 is just around the corner! From Nov 16-18 at the INSA campus in New Delhi. Harsha K Rajasimha, Ph.D., our Founder & CEO, will co-chair and share his insights and expertise at this dynamic 3-day event, packed with workshops, hackathons, startup pitches, and more! “It is an honor and privilege to wake up each day to serve the community of patients with severe rare and genetic diseases.” says Harsha. Last chance to register for this impactful summit shaping the future of rare disease therapies! Want to meet him other stakeholders shaping the future for patients with rare diseases worldwide? Register for this event here: https://hubs.ly/Q02XV6gP0 #bridgingrare #bridge4rare #roar4rare #JeevaClinicalTrials #MeetHarsha #RareDiseases #OrphanDrugs #clinicaltrials #RARESummit2024 #biotechnology #biotechinvirginia #pitch4rare #patientadvocacy
-